SweetValueLab
Write for us

Danaher Corporation — Financial Statements & Ratios

DHR
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0000313616danaher.comAbout DHR
Last close · Oct 16, 2026229.04−2.46 (−1.06%)
Market cap$161.0B

Key indicators

Revenue25.1BTTM+4.6% on a year earlier+3.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
19.9B 17.9B−10.0%22.3B+24.4%29.5B+32.2%31.5B+6.9%23.9B−24.1%23.9B−0.1%24.6B+2.9%25.1B+4.6%26.4B 28.5B 30.3B
— -10.0% 24.4% 32.2% 6.9% -24.1% -0.1% 2.9% 4.6% 7.3% 8.0% 6.5%
$3.74 $4.05+8.3%$4.89+20.7%$8.61+76.1%$9.66+12.2%$6.38−34.0%$5.29−17.1%$5.05−4.5%$5.64+20.0%$8.50 $9.30 $10.23
Profitability
55.8% 55.7%−0.1 pt56.0%+0.2 pt61.0%+5.0 pt60.2%−0.7 pt58.7%−1.5 pt59.5%+0.8 pt59.1%−0.4 pt58.5%−1.1 pt· · ·
17.1% 18.3%+1.1 pt19.0%+0.7 pt25.3%+6.4 pt27.6%+2.3 pt21.8%−5.8 pt20.4%−1.4 pt19.1%−1.3 pt20.4%+2.0 pt· · ·
13.3% 16.8%+3.5 pt16.4%−0.4 pt21.8%+5.5 pt22.9%+1.1 pt19.9%−3.0 pt16.3%−3.6 pt14.7%−1.6 pt15.9%+1.7 pt· · ·
9.4% 9.9%+0.5 pt9.2%−0.8 pt14.2%+5.1 pt14.4%+0.2 pt8.9%−5.5 pt7.9%−1.0 pt6.9%−1.0 pt— · · ·
Cash
3.4B 3.3B−1.5%5.4B+63.4%7.1B+30.4%7.4B+4.3%5.8B−21.5%5.3B−8.4%5.3B−0.7%5.5B+12.4%· · ·
16.9% 18.5%+1.6 pt24.3%+5.8 pt24.0%−0.3 pt23.4%−0.6 pt24.2%+0.8 pt22.2%−2.0 pt21.4%−0.8 pt21.8%+1.5 pt· · ·
433.4M 526.7M+21.5%615.0M+16.8%742.0M+20.7%818.0M+10.2%821.0M+0.4%768.0M−6.5%878.0M+14.3%— · · ·
Balance sheet
0.35x 0.72x+0.37x0.53x−0.18x0.49x−0.04x0.39x−0.10x0.34x−0.05x0.32x−0.02x0.35x+0.03x0.51x+0.17x· · ·
710.20M 725.50M+2.2%718.70M−0.9%736.80M+2.5%737.10M+0.0%743.10M+0.8%737.20M−0.8%716.10M−2.9%707.60M−1.6%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 26, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.